Breast mapping test for finding suspicious spots
Part of Cancer clinical trials.
This trial tests a new Feminai device that maps breast tissue to find suspicious lumps. If you're coming for a routine mammogram or a biopsy, this could help improve detection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 25 and 75 years old.
- You can follow study procedures and return for follow-ups.
- You are willing to sign a consent form.
- You are either having a routine mammogram with normal results (BIRADS 1 or 2) or a biopsy for a suspicious mammogram (BIRADS 4-5).
- You do not have breast implants, metal implants, or a history of current breast cancer treatment.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a device called OneMark that helps doctors find and track breast cancer during surgery and follow-up. It may help make sure the cancer is removed completely.
This study is testing a new, non-invasive scanning device that uses harmless electrical signals to look at breast tissue. If you are already going to a breast clinic appointment, you may be able to join and help us find out if this tool works well.
This study tests a new, safe microwave-based device (MammoWave) to screen for breast cancer. It compares the device's results with standard mammograms to see if it can find cancer early in women at average risk.
This study checks how well MammoWave can help detect breast lesions (areas that may be abnormal) using imaging. It may help doctors confirm findings by combining it with other scans when needed, and sometimes with biopsy results.
This study is testing whether a special MRI scan can help show tiny features inside breast tumors (TMEM). It’s mainly a “feasibility” study, meaning the team is checking if the scan can be done safely and clearly in different types of operable breast cancer.
This trial looks at different methods doctors can use to locate a breast lesion using imaging, so it can be removed accurately during breast-conserving surgery. It may help your care team choose the best localization approach for your type and location of lesion.
Hear when a new Breast Cancer Awareness trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.